These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 129005)

  • 21. Survey of HBag hepatitis infection in a semi-closed community.
    Young BH; Stokes PL; Linehan BJ; Pullon DH
    N Z Med J; 1975 Oct; 82(550):267-9. PubMed ID: 128713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of HBeAg and anti-HBe in an institution for the mentally retarded.
    Gust ID; Dimitrakakis M; Sharma DL
    Aust N Z J Med; 1978 Oct; 8(5):471-3. PubMed ID: 154317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The problem of hepatitis among mentally retarded patients].
    Andrén-Sandberg M
    Lakartidningen; 1973 Dec; 70(51):4750-1. PubMed ID: 4793947
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of relationship between Down's syndrome and maternal exposure to Australia antigen.
    Dietzman DE; Madden DL; Sever JL; Lander JJ; Purcell RH
    Am J Dis Child; 1972 Aug; 124(2):195-7. PubMed ID: 4262231
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of induced abortion on the incidence of Down's syndrome in Hawaii.
    Smith RG; Gardner RW; Steinhoff P; Chung CS; Palmore JA
    Fam Plann Perspect; 1980; 12(4):201-5. PubMed ID: 6449372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB; Strauss D
    J Insur Med; 1997; 29(3):172-84. PubMed ID: 10176367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine].
    García O; Bruguera M; Mayor A; Sánchez-Tapias JM; Vall O; Rodés J
    Enferm Infecc Microbiol Clin; 1990 Mar; 8(3):148-52. PubMed ID: 2151250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.
    Perry E; Chaudhary RK; Cleary TE; Roughley FR
    Can Med Assoc J; 1975 Jan; 112(1):46-8. PubMed ID: 122813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sex difference in the carrier state of Australia (hepatitis-associated) antigen.
    Goodman M; Wainright RL; Weir HF; Gall JC
    Pediatrics; 1971 Dec; 48(6):907-13. PubMed ID: 4256915
    [No Abstract]   [Full Text] [Related]  

  • 30. [Importance of the Australia antigen in infantile pathology].
    Ortoleva V
    Minerva Pediatr; 1975 Apr; 27(12):747-8. PubMed ID: 124012
    [No Abstract]   [Full Text] [Related]  

  • 31. The antibody response of institutionalized Down's syndrome patients to seven microbial antigens.
    Hawkes RA; Boughton CR; Schroeter DR
    Clin Exp Immunol; 1978 Feb; 31(2):298-304. PubMed ID: 148342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte glucose-6 phosphate dehydrogenase (G6PD) and Australia antigen hepatitis in Down's syndrome.
    Sutnick AI; Oski FA; London WT; Millman I; Blumberg BS
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):3-8. PubMed ID: 4257700
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of asymptomatic HBeAG carrier state in a patient with Down's syndrome following human bite.
    Kanda T; Hara H; Hanaoka T; Kobayashi I
    J Med; 1994; 25(6):383-7. PubMed ID: 7769376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of Cytomegalovirus, Epstein-Barr virus and Herpesvirus hominis (types 1 and 2) antibody in institutionalized and non-institutionalized children.
    McMillan BC; Golubjatnikov R; Hanson RP; Sinha SK
    Health Lab Sci; 1977 Oct; 14(4):261-8. PubMed ID: 199558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis-associated (Australia) antigen and Down's syndrome.
    Shiono H; Kadowaki J; Fujiwara T; Nakao T
    Clin Pediatr (Phila); 1975 Dec; 14(12):1150-4. PubMed ID: 127683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic findings correlated with immune response to hepatitis virus B of institutionalized Down syndrome individuals.
    Smith A; Boughton CR; Hawkes RA; Schroeter DR
    Am J Ment Defic; 1982 Sep; 87(2):223-6. PubMed ID: 6214954
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies in Down's syndrome. I. Genetic predisposition to become a carrier of the Au-SH antigen?
    Rittner C; Schwinger E; Stockhausen FG; Dufkova J
    Vox Sang; 1970; 19(3):280-7. PubMed ID: 4251110
    [No Abstract]   [Full Text] [Related]  

  • 38. Australia antigen, autoantibodies and cell-mediated immune responses in patients with Down's syndrome.
    Campion EC; Wangel AG
    Med J Aust; 1975 Apr; 01(15):468-70. PubMed ID: 125374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of persons with Down's syndrome on two projective techniques.
    Brink M; Grundlingh EM
    Am J Ment Defic; 1976 Nov; 81(3):265-70. PubMed ID: 136898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.